Skip to main content
OpenTrials

Clinical trial condition

Triple-negative Breast Cancer

Explore clinical trials studying Triple-negative Breast Cancer. Study availability and eligibility vary by location and protocol.

80 public trials 29 recruiting studies
Refine in advanced search Browse all conditions

Triple-negative Breast Cancer trial results

Active, not recruiting

Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)

NCT02393794

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
Locations
  • University of Kansas Cancer Center - Clinical Research Center Fairway, Kansas, United States
  • University of Kansas Cancer Center - West Kansas City, Kansas, United States
  • University of Kansas Cancer Center - Overland Park Overland Park, Kansas, United States
  • University of Kansas Cancer Center - Westwood Westwood, Kansas, United States
View Trial Details
Completed

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

NCT01805076

Conditions
Breast Diseases, Breast Neoplasms, Estrogen Receptor-negative Breast Cancer, +10 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Enloe Medical Center Chico, California, United States
View all 179 locations
View Trial Details
Completed

Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment

NCT04085276

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • The Fifth Medical Center of PLA General Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Peking University Shougang Hospital Beijing, Beijing Municipality, China
View all 55 locations
View Trial Details
Completed

A Study of Atezolizumab Plus Nab-Paclitaxel in the Treatment of Unresectable Locally Advanced or Metastatic PD-L1-Positive Triple-Negative Breast Cancer

NCT04148911

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • CEMIC Buenos Aires, Argentina
  • Sanatorio de la Mujer Rosario, Argentina
  • Organizacion Medica de Investigacion San Nicolás, Argentina
  • Instituto de Radiomedicina, IRAM Santiago, Chile
View all 67 locations
View Trial Details
Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details

Related conditions